Review of clinical trials to be accelerated in new fast-track service for non-COVID 19 research

The Health Research Authority has launched a new service for pharmaceutical companies and research organisations seeking to start clinical trials of medicines in the UK. It will offer swift review of global trials and first-in-human studies, developing medicines in key areas of patient need such as heart disease and diabetes.